Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Med.

Sec. Gene and Cell Therapy

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1710876

Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada

Provisionally accepted
Jean-Sébastien DelisleJean-Sébastien Delisle1,2,3,4*Diane FournierDiane Fournier5*Kim SanterreKim Santerre4Samuel RochetteSamuel Rochette5Ma'n H. ZawatiMa'n H. Zawati4,6Maude Dumont-LagacéMaude Dumont-Lagacé7,8Simon TurcotteSimon Turcotte10,4,9Jason Robert GuertinJason Robert Guertin11,12,13,4Patrick VermettePatrick Vermette14,15,4Jacques P. TremblayJacques P. Tremblay16,17,4Maxime ParisottoMaxime Parisotto18Christian BeausejourChristian Beausejour19,20,4Jean-Francois GelinasJean-Francois Gelinas21Louisa PetropoulosLouisa Petropoulos21Natasha KekreNatasha Kekre22Stephanie MichaudStephanie Michaud23Mélanie DieudéMélanie Dieudé24,25,26*
  • 1Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Canada
  • 2Institut d’hématologie, oncologie et thérapie cellulaire (iHOT), Hôpital Maisonneuve-Rosemont, Montréal, Canada
  • 3Département de médicine, Faculté de médecine, Université de Montréal, Montréal, Canada
  • 4Québec Cell, Tissue, and Gene Therapy Network, Montréal, Canada
  • 5Transfusion Medicine, Héma-Québec, Montréal, Canada
  • 6Centre of Genomics and Policy, Department of Human Genetics, Faculty of Medicine and Health Sciences, McGill University, Montréal, Canada
  • 7Héma-Québec, Montreal, Canada
  • 8Borealis Medical Writing, Montréal, Canada
  • 9Cancer Axis, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Canada
  • 10Hepatopancreatobiliary Surgery & Liver Transplantation Service, Centre hospitalier de l'Université de Montréal, Montréal, Canada
  • 11Axe santé des populations et pratiques optimales en santé, Centre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Québec, Canada
  • 12Département de médecine sociale et préventive, Faculté de médecine, Université Laval, Québec, Canada
  • 13Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Québec, Canada
  • 14Department of Chemical and Biotechnological Engineering, Laboratoire de bio-ingénierie et de biophysique de l'Université de Sherbrooke, Sherbrooke, Canada
  • 15Faculté de médecine et des sciences de la santé, Centre de recherche du Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Canada
  • 16Centre de recherche du Centre hospitalier universitaire de Québec-Université Laval, Québec, Canada
  • 17Département de médecine moléculaire, Université Laval, Québec, Canada
  • 18adMare Bioinnovations, Montreal, Canada
  • 19Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada
  • 20Département de pharmacologie et physiologie, Faculté de médecine, Université de Montréal, Montréal, Canada
  • 21Centre C3i, Montréal, Canada
  • 22Division of Hematology, Department of Medicine, The Ottawa Hospital, Ottawa, Canada
  • 23BioCanRx, Ottawa, Canada
  • 24Medical Affairs and Innovation, Héma-Québec, Québec, Canada
  • 25Axe immunopathologie, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, Canada
  • 26Département de microbiologie, infectiologie et immunologie, Université de Montréal, Faculté de médecine, Montréal, Canada

This article is a correction to:

  1. Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

In the published article, the author contribution and conflict of interest statements were missing the information of author Jean-François Gélinas, who was erroneously excluded from the author list.A correction has been made to the section Author Contributions to add the contributions of Jean-François Gélinas. The added sentence appears below: "J-FG: Data curation, Formal Analysis, Writing -review and editing."A correction has also been made to the section Conflict of Interest to add information on author Jean-François Gélinas. This sentence previously stated :"LP was employed by Centre C3i Inc."The corrected sentence appears below: "J-FG is and LP was employed by Centre C3i Inc."

Keywords: Immune effector cell immunotherapy, research funding, economic evaluation, Ethics, Biological Drug approval, Cell and tissue manufacturing

Received: 22 Sep 2025; Accepted: 29 Sep 2025.

Copyright: © 2025 Delisle, Fournier, Santerre, Rochette, Zawati, Dumont-Lagacé, Turcotte, Guertin, Vermette, Tremblay, Parisotto, Beausejour, Gelinas, Petropoulos, Kekre, Michaud and Dieudé. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Jean-Sébastien Delisle, js.delisle@umontreal.ca
Diane Fournier, diane.fournier@hema-quebec.qc.ca
Mélanie Dieudé, melanie.dieude@hema-quebec.qc.ca

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material